Sana Biotechnology

IPO

Engineered cells as medicines

Public · Seattle, United States · Founded 2018 · $1.4B raised

Employees
201–500
Founded
2018
Business Model
B2B
Website
sana.com
Total Funding
$1.4B
Last Round
$821.0M Series DJun 2020
Rounds
5
Type
Public

About

Sana Biotechnology is focused on creating engineered cells as medicines to repair and control genes or replace damaged cells, targeting diseases like diabetes, B-cell cancers, and autoimmune disorders. With operations in Seattle, Cambridge, and South San Francisco, Sana leverages expertise in cell and gene therapy to develop curative therapies.

Summary

Sana Biotechnology is a Biotech company based in Seattle, United States, founded in 2018. It has raised $1.4B in total across 5 rounds, most recently a $821.0M Series D round in Jun 2020. Investors include ARCH Venture Partners, Flagship Pioneering and SoftBank.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOFeb 2021
$587.5M

Sign up to see all 6 rounds

Seed through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sana Biotechnology on Indexed.vc
<a href="https://indexed.vc/companies/sana-biotechnology"><img src="https://indexed.vc/api/badge/company/sana-biotechnology" alt="Sana Biotechnology on Indexed.vc" width="260" height="76" /></a>